Unither Pharmaceuticals
FranceWho owns Unither Pharmaceuticals?
Unither Pharmaceuticals is a French Pharma company, currently owned by IK Partners since 2023 and 2 other investors. It changed hands in 2017, when Equistone Partners sold.
Hand-verified · 3 sources · updated 2026-09-30
Open JSON · CC-BY
Key facts
- ·Co-held by Keensight Capital, Ardian and IK Partners since 2017.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected
Equistone Partners sold Unither Pharmaceuticals to Ardian in 2017 after 6 years.
More from IK Partnership Fund II
Other portfolio companies in the same fund.
UK
Netherlands
GermanyMore PE-backed in Pharma
Comparable pharma deals from other GPs.
US
SpainQuestions
Who owns Unither Pharmaceuticals?
Unither Pharmaceuticals is currently owned by IK Partners, Keensight Capital and 1 other, through IK Partnership Fund II, since 2023.
When did IK Partners and 2 others acquire Unither Pharmaceuticals?
IK Partners and 2 others acquired Unither Pharmaceuticals in 2023.
Who did Unither Pharmaceuticals sell to?
Equistone Partners sold Unither Pharmaceuticals to Ardian in 2017 (Secondary).
Who has owned Unither Pharmaceuticals over time?
Unither Pharmaceuticals has been through 4 private-equity ownership periods: Equistone Partners · via Equistone Fund IV · 2011–2017 · sold to Ardian · (Secondary); Keensight Capital · via Keensight Nova V · since 2017; Ardian · since 2017; IK Partners · via IK Partnership Fund II · since 2023.